Stress hyperglycemia is common in critically ill and injured patients. 1 Prior to 2001, stress hyperglycemia was defined as a plasma glucose above 180 to 200 mg/dL. 2,3 However, following the Leuven Intensive Insulin Therapy Trial, presented as a proof-of-concept study, the American Association of Clinical Endocrinologists, the American Diabetes
Association, and other authorities suggested that stress hyperglycemia be considered in any critically ill patient with a blood glucose in excess of 110 mg/dL. 4-7 In the Leuven Intensive Insulin Therapy Trial, 12% of patients had a baseline blood glucose above 200 mg/dL on the day following ICU admission. However, 74.5% of patients had a baseline blood glucose above